A 6-Week Safety & Efficacy Study of Combination Intraocular Pressure-Lowering Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension - Tabular View

Tracking Information

First Received Date ^ICMJE

January 3, 2003

Last Updated Date

March 3, 2006

Start Date ^ICMJE

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00051194 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

A 6-Week Safety & Efficacy Study of Combination Intraocular Pressure-Lowering Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

Official Title ^ICMJE

A 6-Week Safety and Efficacy Study of Combination IOP-Lowering Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension.

Brief Summary

To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.

Detailed Description

Study Phase

Phase II

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Condition ^ICMJE

Glaucoma, Open-Angle
Ocular Hypertension

Intervention ^ICMJE

Drug: Combination IOP Lowering Therapy

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

Primary Completion Date

Eligibility Criteria ^ICMJE

Adult patients of any race and either sex with open angle glaucoma or ocular hypertension.

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00051194

Responsible Party

Study ID Numbers ^ICMJE

C-02-03

Study Sponsor ^ICMJE

Alcon Research

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Alcon Investigators

Alcon Research

Information Provided By

Alcon Research

Verification Date

March 2006

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP